drugset / Trial / NCT03894813

Probiotics as Adjuvant Treatment for Bacterial Vaginosis

NCT03894813 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators are trying to determine if oral probiotics (Umeta-Miyue, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) (30 days)with metronidazole vaginal suppositories(7 days) is better than using metronidazole vaginal suppositories only in preventing the recurrence of bacterial vaginosis (BV).

Timeline

Start
2019-03-26
Primary completion
2020-12-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus reuteri RC-14 Other / unclassified — Oral
Subject Lactobacillus rhamnosus GR-1 Other / unclassified — Oral
Subject Umeta-Miyue Other / unclassified — Oral
Comparator Metronidazole Small molecule 1 unknown Other

Indications